BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36204747)

  • 1. Environmental, social, and governance information disclosure and stock price crash risk: Evidence from Chinese listed companies.
    Xu N; Liu J; Dou H
    Front Psychol; 2022; 13():977369. PubMed ID: 36204747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of green financial development on stock price crash risk from the perspective of information asymmetry in Chinese listed companies.
    Zhang Z; Ding Y
    Environ Sci Pollut Res Int; 2023 Aug; 30(37):87199-87214. PubMed ID: 37418190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of environmental information disclosure on stock price synchronicity in China.
    Yang Y; Zhang J; Li Y
    Heliyon; 2023 May; 9(5):e16271. PubMed ID: 37251833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESG Performance and Stock Price Volatility in Public Health Crisis: Evidence from COVID-19 Pandemic.
    Zhou D; Zhou R
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does ESG performance affect stock returns? Empirical evidence from listed companies in China.
    Yin XN; Li JP; Su CW
    Heliyon; 2023 May; 9(5):e16320. PubMed ID: 37305472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formative experience and stock price crash risk: Evidence from China's "Down to the Countryside" movement.
    Wu M; Zhang Y; Shi D
    Front Psychol; 2022; 13():971101. PubMed ID: 36312051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of lazy information disclosure on stock price crash risk: Empirical evidence from China.
    Shi X; Cao X; Xu W; Hou Y; Shang L
    PLoS One; 2023; 18(8):e0288552. PubMed ID: 37594991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do disclosure of ESG information policies inhibit the value of heavily polluting Enterprises?-Evidence from China.
    Liu Y; Deng Y; Liu Y; Li C; Ankrah Twumasi M; Cheng Y
    Heliyon; 2023 Dec; 9(12):e22750. PubMed ID: 38125493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can companies get more government subsidies through improving their ESG performance? Empirical evidence from China.
    Zhang X; Zhang J; Feng Y
    PLoS One; 2023; 18(10):e0292355. PubMed ID: 37788255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental disclosure practices in mixed ownership models: A study of Chinese private enterprises.
    Song T; Xiong A
    PLoS One; 2023; 18(11):e0295399. PubMed ID: 38033167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of companies disclosing ESG reports in multiple languages on the enthusiasm of foreign investors for holding shares.
    Bao R; Wei L
    PLoS One; 2024; 19(3):e0299643. PubMed ID: 38452011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the fast track: the benefits of ESG performance on the commercial credit financing.
    Huang Y; Bai F; Shang M; Ahmad M
    Environ Sci Pollut Res Int; 2023 Jul; 30(35):83961-83974. PubMed ID: 37351751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyst optimism, information disclosure, and stock price collapse risk: Empirical insights from China's A-share market.
    Li Y; Zhang Y; Ma R; Wang R
    PLoS One; 2024; 19(3):e0297055. PubMed ID: 38547105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterprise digital transformation's impact on stock liquidity: A corporate governance perspective.
    Liu H; Zhu J; Cheng H
    PLoS One; 2024; 19(3):e0293818. PubMed ID: 38507430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the impact of ESG rating on green technology innovation in enterprises: An empirical study based on informal environmental governance.
    Chang Y; Wang S
    J Environ Manage; 2024 May; 358():120878. PubMed ID: 38636420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green finance and environmental, social, and governance: evidence from Chinese listed companies.
    Wu J; Liew CY
    Environ Sci Pollut Res Int; 2023 Nov; 30(51):110499-110514. PubMed ID: 37792189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information disclosure of COVID-19 specific medicine and stock price crash risk in China.
    Duan J; Lin J
    Financ Res Lett; 2022 Aug; 48():102890. PubMed ID: 35463295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?-Empirical Evidence From COVID-19.
    Li J; Ma Y; Shi B; Yang Y
    Front Public Health; 2021; 9():812253. PubMed ID: 35155358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESG performance, capital financing decisions, and audit quality: empirical evidence from Chinese state-owned enterprises.
    Zahid RMA; Saleem A; Maqsood US
    Environ Sci Pollut Res Int; 2023 Mar; 30(15):44086-44099. PubMed ID: 36681761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The executive pay gap and stock price crash risk: Promotion or suppression?
    Liu Q; Pan Z
    Front Psychol; 2022; 13():913082. PubMed ID: 36687917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.